Golden Sun Health Technology Group Limited Announces Annual General Meeting Results
At the AGM, the shareholders of the Company adopted ordinary resolutions that:
- Re-elected Mr.
Xueyuan Weng as a director of the Company to hold office until the next annual general meeting; - Re-elected Mr.
Liming Xu as a director of the Company to hold office until the next annual general meeting; - Re-elected Ms.
Peilin Ji as a director of the Company to hold office until the next annual general meeting; - Re-elected Mr.
Yidong Hao as a director of the Company to hold office until the next annual general meeting; - Re-elected Mr.
Zhenghua Yu as a director of the Company to hold office until the next annual general meeting; - Re-elected Mr.
Xiao Jin as a director of the Company to hold office until the next annual general meeting; - Elected Mr.
Xijing Xu as a director of the Company to hold office until the next annual general meeting. - Ratified the appointment of Assentsure PAC as independent registered public accounting firm for the Company;
- Ratified the adoption of a financial year ending on
September 30 and beginning onOctober 1 of each year.
Each shareholder had one vote for each Class A ordinary share or five votes for each Class B ordinary share. The shares attended the AGM in person or by proxy represented approximately 63.84% of the total outstanding votes represented by the Company's total ordinary shares outstanding at the close of business in the Shanghai on the record date of August 7, 2024. Each of the above resolutions was approved by 99.96% or above of the total votes cast at the AGM.
Mr.
About
Established in 1997 and headquartered in
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “approximates,” “assesses,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's annual report and other filings with the
For more information, please contact:
Investor Relations Department
Email: ir@cngsun.com
Ascent Investor Relations LLC
President
Phone: +1 646-932-7242
Email: investors@ascent-ir.com
Source: Golden Sun Health Technology Group Limited